Overview

Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract

Status:
Unknown status

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of three doses of C-KAD Ophthalmic Solution in patients with loss of visual function due to age-related nuclear cataract

Phase:

Phase 2

Details

Lead Sponsor:

Chakshu Research, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions